Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter study

BMC Medicine · Published 2026-08-04 · DOI 10.1186/s12916-026-05086-2

Free full text

Authors (30)

Marianna Garofoli, Maria Iole Natalicchio, Giuseppina Bruno, Aldo Rosano, Brigida Anna Maiorano, Sabrina Rossetti, Sarah Scagliarini, Lorena Incorvaia, Luigi Formisano, Ilaria Toma, Guido Giordano, Giovanna Pecoraro, Francesco Grillone, Laura Palumbo, Marco Pisino, Marta Palladino, Concetta Rita Di Pippo, Valeria Bafunno, Nicole Brighi, Chiara Casadei, Cristian Lolli, Maria Concetta Cursano, Vincenzo Emanuele Chiuri, Pasquale Rescigno, Emiliano Tamburini, Francesca Sanguedolce, Fabio Calabrò, Ugo De Giorgi, Matteo Landriscina, Vincenza Conteduca

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Garofoli, M., Natalicchio, M., Bruno, G., et al. (2026). Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter study. BMC Medicine. https://doi.org/10.1186/s12916-026-05086-2

Related articles